Home » Stocks » NNVC

NanoViricides, Inc. (NNVC)

Stock Price: $4.02 USD -0.16 (-3.83%)
Updated Jul 30, 2021 4:00 PM EDT - Market closed
Market Cap 46.25M
Revenue (ttm) n/a
Net Income (ttm) -8.62M
Shares Out 10.95M
EPS (ttm) -0.85
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 30
Last Price $4.02
Previous Close $4.18
Change ($) -0.16
Change (%) -3.83%
Day's Open 4.17
Day's Range 4.00 - 4.61
Day's Volume 887,631
52-Week Range 2.85 - 8.71

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

With the coronavirus changing the world in 2020, it makes sense that there's a spotlight on science to prevent viruses from growing into pandemics. While Pfizer (NYSE: PFE) and Moderna Inc. (NASDAQ: MRN...

1 month ago - Benzinga

SHELTON, CT / ACCESSWIRE / May 17, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicin...

2 months ago - Accesswire

Immutep Limited (IMMP) stock is soaring higher on Thursday despite a lack of recent news coming from the company but there is a reason why. The post IMMP Stock: Why Is Biotech Company Immutep Rocketing ...

Other stocks mentioned: BMY, CLVS, GSK, IMMP, ITRM, NVS
4 months ago - InvestorPlace

SHELTON, CT / ACCESSWIRE /  March 9, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines ...

4 months ago - Accesswire

Shares of nano-cap biopharma NanoViricides, Inc. (NASDQ: NNVC) were trading solidly higher Tuesday following a positive data readout. What Happened: Two NanoViricides COVID-19 clinical drug candidates —...

4 months ago - Benzinga

NanoViricides (NNVC) stock is on the rise Tuesday after revealing results from the company's drug candidates to treat the coronavirus. The post NNVC Stock: The COVID-19 Drug News That Has NanoViricides ...

4 months ago - InvestorPlace

SHELTON, CT / ACCESSWIRE / March 2, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicine tech...

4 months ago - Accesswire

NanoViricides Inc (NYSE: NNVC) has reported data from animal studies evaluating its broad-spectrum antiviral drug candidate NV-CoV-2 to treat COVID-19 infections.  The treatment candidate was well toler...

5 months ago - Benzinga

New York, New York--(Newsfile Corp. - November 18, 2020) - NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a...

8 months ago - Newsfile Corp

As the confirmed Covid-19 death toll nears the 1.3 million mark, pharma and biotech companies all over the world are making progress in their attempts to develop a cure for the disease.

8 months ago - GuruFocus

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of NanoViricides, Inc. (“NanoViricides” or “the Company”) (NYSE: NNVC...

10 months ago - Business Wire

As the world struggles to return to normalcy in the wake of the Covid-19 pandemic, pharma companies are in the process of building various potential therapies to counter the virus.

Other stocks mentioned: GILD
10 months ago - GuruFocus

PHILADELPHIA, Sept. 8, 2020 /PRNewswire/ -- Kehoe Law Firm, P.C.

10 months ago - PRNewsWire

NanoViricides, Inc. (AMEX:NNVC) has consistently been in the news over the past few months owing to its efforts to develop a novel drug to counter the novel coronavirus, SARS-CoV-2.

10 months ago - GuruFocus

New York, New York--(Newsfile Corp. - August 31, 2020) - NanoViricides, Inc.

11 months ago - Newsfile Corp

The Company's successful fundraising and inclusion in the Russell Microcap(R) Index comes after a series of promising test results for its COVID-19 drug candidatesShelton, Connecticut--(Newsfile Corp. -...

1 year ago - Newsfile Corp

LOS ANGELES--(BUSINESS WIRE)---- $NNVC #fraud--Glancy Prongay & Murray LLP, a National Class Action Law Firm, Announces Investigation of NanoViricides, Inc. (NNVC) on Behalf of Investors

1 year ago - Business Wire

SAN FRANCISCO, July 15, 2020 /PRNewswire/ -- Hagens Berman urges investors in NanoViricides, Inc. (NNVC) to submit their losses now.

1 year ago - PRNewsWire

Cashing in on Coronavirus: Biopharma NanoViricides sees stock soar on coronavirus claims

YouTube video

As the coronavirus was spreading in China, a small biopharma company, NanoViricides, claimed it was close to clinical trials for a treatment.

1 year ago - CNBC Television

As the coronavirus was spreading in China, a small biopharma company, NanoViricides, claimed it was close to clinical trials for a treatment. A CNBC investigation found the 15-year-old company has never...

1 year ago - CNBC

NanoViricides Inc. (NYSE: NNVC) made another stride in the fight against COVID-19, and investors have to be happy about it.

1 year ago - 24/7 Wall Street

NanoViricides (NYSE: NNVC) shares are trading higher after the company announced the drug candidates it's developing against the coronavirus demonstrated safety and tolerability in an animal model.

1 year ago - Benzinga

The global nanotechnology market could exceed $125 billion by 2024, as it continues to impact technology, energy, defense, and even food.

Other stocks mentioned: TMO, TSM
1 year ago - InvestorPlace

Biotech and pharma companies all over the world are engaged in the development and testing process of their respective drug and vaccine candidates to counter the Covid-19 pandemic.

1 year ago - GuruFocus

NanoViricides Inc. (NNVC) has been one of the most widely covered micro caps within the antiviral space ever since the outbreak of the novel coronavirus (Covid-19).

1 year ago - GuruFocus

Anil Diwan typically runs on six hours of sleep, but he’s no stranger to two-week stretches of three hours or less.

1 year ago - Benzinga

Markets looked like they would be crushed yet again on Monday despite the emergency Federal Reserve rate cut announced on Sunday.

Other stocks mentioned: ALT, AYTU, CLX, CODX, DGX, GILD, INO ...
1 year ago - 24/7 Wall Street

Markets were crushed again on Thursday after President Trump announced a travel ban to Europe on Wednesday night.

Other stocks mentioned: ALT, AYTU, CLX, CODX, DGX, GILD, INO ...
1 year ago - 24/7 Wall Street

COVID-19 has rocked markets and caused panic across the world. While investors are feeling the pain as global supply chains may become constricted, playing on COVID-19 stocks has proven very lucrative.

Other stocks mentioned: CLX, CODX, GILD, LAKE, MRNA, NVAX, REGN
1 year ago - 24/7 Wall Street

The COVID-19 virus has sent the market and the global economy into a tailspin. The Organisation for Economic Co-operation and Development slashed its global growth forecast for 2020 Monday by 0.5 points...

Other stocks mentioned: COCP, GILD, GSK, INO, JNJ, MRNA, NVAX ...
1 year ago - Benzinga

The COVID-19 outbreak has proved to be a catalyst for biotechs. Some issues that were wallowing in penny stock territory have posted stratospheric gains in the wake of efforts to develop diagnostic test...

Other stocks mentioned: ENZ, OPK, SPEX
1 year ago - Benzinga

The coronavirus fear is now a pandemic, at least in the markets. All major American averages were down over 3% on Friday, after what has been the worst week since the financial crisis more than a decade...

Other stocks mentioned: ALT, CLX, GILD, INO, LAKE, NVAX, ZM
1 year ago - 24/7 Wall Street

Shares of NanoViricides Inc. NNVC, +10.52% soared 33% in premarket trading Monday, after the antiviral therapies company, which previously announced it was working on a COVID-19 treatment, said it had s...

1 year ago - Market Watch

NanoViricides Will Return To $3-$5 As Soon As The Coronavirus Newsflow Fades

1 year ago - Seeking Alpha

The story that has dominated this past week is that China is facing an outbreak of the coronavirus, and more countries around the world are seeing cases pop up.

Other stocks mentioned: AEMD, INO, NVAX
1 year ago - 24/7 Wall Street

China is facing an outbreak of the coronavirus, and more countries around the world are seeing cases pop up.

Other stocks mentioned: AEMD, INO, NVAX, SRPT
1 year ago - 24/7 Wall Street

Monday morning brought a huge sell-off in the market as more and more people are concerned about the growing impact of this new coronavirus.

Other stocks mentioned: AHPI, APT, BCRX, CERS, CODX, DYAI, INO ...
1 year ago - 24/7 Wall Street

Shares of a handful of vaccine makers, diagnostics companies and manufacturers of medical supplies, like masks, rallied again in premarket trading on Monday over growing public concern about the new cor...

Other stocks mentioned: AHPI, CODX, INO, NVAX
1 year ago - Market Watch

Airlines, hotels, casinos and stocks linked to Wuhan, China, continue to fall as fear of the coronavirus deters international travel and all but halts activity in the virus epicenter.

Other stocks mentioned: AEMD, APT, AZN, BCRX, CBLI, CERS, CODX ...
1 year ago - Benzinga

Shares of vaccine makers rose sharply again on Thursday, amid rising concerns about the outbreak of a new coronavirus in Wuhan, China that has led the authorities to quarantine the city of 11 million.

Other stocks mentioned: MRNA, NVAX, XBI
1 year ago - Market Watch

About NNVC

NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. Its products pipeline includes HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis. The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpa... [Read more...]

Industry
Biotechnology
Founded
2005
Stock Exchange
NYSEAMERICAN
Ticker Symbol
NNVC
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to one analyst, the rating for NanoViricides stock is "Strong Buy" and the 12-month stock price forecast is 14.50.

Price Target
$14.50
Analyst Consensus: Strong Buy